Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine, Velcade, and Rituximab in Follicular Lymphoma
NCT01186458Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- Oct 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), sponsored by Hoosier Cancer Research Network. Started Oct 2010; status: terminated.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01186458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01186458.